ASH 2024 Highlights
ASH 2024 Highlights:
Advancing Therapeutic Scalability, Precision Medicine, and Next-Gen Trial Designs
Advancements from AUGS PFD Week
Exploring Advancements in Personalized Medicine, Sexual Health, Essential Endpoints, and Health Equity in Clinical Trials Â
Breast Cancer Awareness Month 2024
Breast cancer persists as a critical global health challenge, with an estimated 1 in 8 women facing a diagnosis over...
Medpace Expands Ophthalmology Medical Leadership Team
Medpace is pleased to announce the addition of a new ophthalmology expert, Dr. Karen Klugo, to the medical leadership team.Â
[On-Demand Webinar] Accelerating Psychiatry Clinical Trials Through a Patient-Centric Approach: Real Patients, Real Outcomes
In this webinar, Medpace neuroscience clinical trial experts will explore strategies for successfully conducting psychiatry clinical trials.
Oncology Breakthroughs – ESMO Congress 2024
Upon their return from ESMO Congress 2024 and in recognition of World Cancer Research Day, Medpace oncology experts identified three...
[On-Demand Webinar] Innovative Approaches in MASH Clinical Research
The evolving landscape of metabolic dysfunction-associated steatohepatitis (MASH) research demands precise and reliable methodologies to ensure accurate data collection and...
Medpace Expands Rare Disease & Metabolic Medical Leadership Team
Medpace is pleased to announce the addition of a new rare disease and metabolic expert, Dr. Loren Peña, to the medical leadership team.
Expert Insights: Late-Breaking Science Emerging from ACC.24
At Medpace, we remain committed to shaping the future of cardiovascular care through our ongoing work with sponsors and research...
Q&A with Medpace Rheumatology Medical Experts: A Collaborative and Cross-Therapeutic Approach
In this brief interview, we learn about the expertise that Dr. Docena and Dr. Head bring to Medpace, building a strong Medpace medical leadership team…